East Carolina University/Vidant Medical Center Greenville, NC
Gbeminiyi O. Samuel, MD, MSPH1, MaryKate Kratzer, MD2, Elijah E. Asagbra, PhD, MHA, CPHQ3, Josef Kinderwater, MD4, Karissa Lambert, MD5, Shiva Poola, MD4, Jennifer Udom, MD1, Muna Mian, MD1, Eslam O. Ali, MD1; 1Vidant Medical Center, Greenville, NC; 2East Carolina University/Vidant Medical Center, Greenville, NC; 3Department of Health Sciences and Information Management, Greenville, NC; 4East Carolina University, Greenville, NC; 5Vidant Medical Center/ECU Brody School of Medicine, Greenville, NC
Introduction: Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer-related deaths in the United States. Still, 1 in 3 adults aged 50 to 75 years have not been screened for colorectal cancer. Methods: This retrospective cross-sectional study conducted between July 1, 2018 and June 30, 2019 examined 2,428 patients aged 50 to 75 years from the East Carolina University (ECU) Internal Medicine (IM) clinic to determine the barriers and facilitators to CRC screening in eastern North Carolina. Eligible adults were those who had a fecal occult blood test (FOBT) or fecal immunochemical test (FIT) in the past year, Cologuard in the past 3 years, flexible sigmoidoscopy/virtual colonoscopy in the past 5 years, or colonoscopy in the past 10 years. Data on patient socioeconomic status, comorbidities, and other determinants of health compliance were included as covariates. Data extracted included race, gender, marital status, family history of colorectal cancer, no-show rate, employment status, education, travel distance to clinic, hypertension, diabetes, congestive heart failure, end-stage renal disease, obstructive sleep apnea, COPD, provider training, and patient compliance with other health screenings. Results: This study revealed that age (OR= 1.058; p = 0.017), no-show rate percent (OR= 0.962; p < 0.05), patient history of obstructive sleep apnea (OR= 1.875; p = 0.025), compliance with flu vaccinations (OR= 1.673; p < 0.05), compliance with screening mammograms (OR= 2.130; p < 0.05), and compliance with screening pap smears (OR= 2.708; p < 0.05) were important factors in determining whether a patient will receive CRC screening. Additionally, data on the type of CRC screening test performed was available for 1,618 patients who were up to date on their CRC screening. In this subset of patients, 92.82% indicated that their CRC screening was performed via colonoscopy, 2.97% were screened using Cologuard, 1.79% were screened using flexible sigmoidoscopy, 1.42% reported screening with FOBT, and 0.99% reported screening with CT Colonography. Discussion: Our study revealed that the age of patient, history of sleep apnea, compliance with other health maintenance tests were significant facilitators to CRC screening, while no-show rate percent was a significant barrier in our patient population. This study will be of benefit to physicians as they consider barriers to patient adherence to CRC screening.
Supplemental Information- Facilitator and Barriers of Colorectal cancer screening
Disclosures: Gbeminiyi Samuel indicated no relevant financial relationships. MaryKate Kratzer indicated no relevant financial relationships. Elijah Asagbra indicated no relevant financial relationships. Josef Kinderwater indicated no relevant financial relationships. Karissa Lambert indicated no relevant financial relationships. Shiva Poola indicated no relevant financial relationships. Jennifer Udom indicated no relevant financial relationships. Muna Mian indicated no relevant financial relationships. Eslam Ali indicated no relevant financial relationships.